Trump moves to restrict access to HIV, Depression, and Cancer medications for people on Medicare D

1369
TIME / YouTube 3 Companies Recall Blood Pressure Medications 1546520490.jpg...
TIME / YouTube

The New York Times reported that the Trump regime has moved forward on plans to restrict access to life-saving medications through Medicare Part D.

Health insurance plans, the Times reports “would under the proposal, reduce the number of prescription drugs that must be made available to people with cancer, AIDS, depression, schizophrenia”.

Robert Pear writes:

Approximately 45 million people have outpatient drug coverage through Part D of Medicare. Benefits are delivered by prescription drug plans offered by insurance companies under contract with Medicare.

The insurers secure discounts on many medicines by negotiating prices with drug manufacturers. If they could exclude certain drugs in the six therapeutic classes, they could negotiate better deals, the Trump administration said.

snip

The coverage requirement has been in place since it was adopted by the George W. Bush administration in 2006 to ensure that Medicare beneficiaries would have access to “all or substantially all drugs” in the six treatment categories.

Trump administration officials say that drug makers have little incentive to negotiate because they know that Medicare’s prescription drug plans must cover almost all drugs in the six protected classes: antidepressants; antipsychotic medicines, used to treat schizophrenia and certain related disorders; immunosuppressant drugs, to prevent rejection of organ transplants; anti-epilepsy drugs; antiretrovirals, used in treating H.I.V./AIDS; and many cancer drugs.

POZ Magazine comments on the news reported by the New York Times.

“The Trump administration proposal is bad medicine and dangerous to people living with HIV,” Carl Schmid, the deputy executive director of the advocacy group The AIDS Institute, told the Times. “Not all HIV medications are the same. The Medicare Part D program is working well for people with HIV, and there is no reason to take these draconian actions.”

What’s more, the proposal could allow insurers to require a client to obtain prior authorization for a medication as well as to try a cheaper medicine before the insurer would cover a costlier one for the same condition—the latter requirement is a process known as step therapy.

“Step therapy is unheard of in the treatment of HIV due to the danger of developing resistance to an entire class of drugs and potential side effects,” writes The AIDS Institute in a related press release condemning the Trump plan.

“This proposal,” the institute continues, “runs contrary to current U.S. government HIV treatment guidelines, which state that prior authorizations for HIV drugs ‘result in fewer prescriptions filled and increased nonadherence….and have substantially reduced timely access to medications.’”

Thankfully, Nancy Pelosi and the new Democratic Congress will be able to nip this boneheaded plan in the bud. This is why we vote.


Excellent read from CNBC.

“The concern however is people lose access to specific medications” because plans stop providing them, Juliette Cubanski, associate director of the Program on Medicare Policy at Kaiser Family Foundation, told CNBC. “And that concern is outweighed by any potential savings.”

snip

The current proposal, which is open for public comment until Jan. 25, would still require insurers to cover at least two drugs in every therapeutic category. But they could exclude some protected-class drugs when prices increase faster than the rate of inflation or when new drug formulations “are not a significant innovation over the original product,” according to Medicare and Medicaid Administrator Seema Verma.

Pharmaceutical companies “have been able to say you have to cover my drug no matter what and have to pay whatever I want on my plan,” Health and Human Services Secretary Alex Azar said Tuesday on CNBC’s “Squawk Box.” That ends under this proposal, he said.

Spending on Medicare Part D drugs totaled $137 billion in 2015, according to Kaiser. Total health care spending in the U.S. represented 18 percent of gross domestic product, according to Medicare, and is expected to continue to rise.

Thank you to all who already support our work since we could not exist without your generosity. If you have not already, please consider supporting us on Patreon to ensure we can continue bringing you the best of independent journalism.

Leave a Comment

3 Comments on "Trump moves to restrict access to HIV, Depression, and Cancer medications for people on Medicare D"

avatar
  Subscribe  
newest oldest most voted
Notify of
Denise Consiglio
Guest
Denise Consiglio

Anyone who doubted that this man is a monster better see it now!

fishouttaH2o
Guest
fishouttaH2o
The Insurance companies are death panels that get to decide randomly who gets to live & who gets to die. The ACA forced them to take people with pre-existing conditions & this legislation allows them to decide whether to treat them or not. It’s the same racket that’s always gone on. They have to give you an insurance policy. They do not have to give you access to Dr., medications, or treatment. The way the impostor president thinks is they’re Medicare patients, they’re old, they’re costing society money, we can’t afford them, let them die. Problem solved & money saved… Read more »
Impeach trump
Guest
Impeach trump

He is truly Hitler-reincarnate and hates the American people-more people than not have family members within each category-we are forced to have Medicare but let’s not cover prescriptions and let them just die….when will he be impeached and gone?